Terese Saplys is an associate in the London office of Latham & Watkins and a member of the firm’s Data & Technology Transactions Practice.
Ms. Saplys advises on a broad range of commercial issues with a focus on technology and intellectual property transactions, including transactional intellectual property matters, commercial contracts, business separations and transitional services arrangements, e-commerce, emerging companies matters, and data protection. She has advised clients from a range of sectors, including information technology and digital media and healthcare and life sciences.
In 2017, Ms. Saplys advised CVC Capital Partners on various aspects of their acquisition of the women’s health business of pharmaceuticals company Teva. Following the completion of the acquisition in 2018, Ms. Saplys was seconded to Theramex as their sole in-house legal counsel, covering matters from day-to-day operational support to advising on strategic future transactions prior to Theramex appointing a general counsel. Since then, Ms. Saplys has advised various clients on collaboration agreements for the development and/or distribution of new drug therapies. She has also advised various clients on commercial, licensing, regulatory, and data protection aspects of acquisitions of various healthcare and life sciences businesses.